Richard Stone
David Kessler, the controversial commissioner of the U.S. Food and Drug Administration, announced last week that he would leave the agency after 6 years. Among the unfinished business is a plan to strengthen science at the agency and defend the agency against critics who don't think a regulatory agency should be doing research at all.